Cell therapy and tissue engineering (TE) are considered alternative therapeutic approaches to organ transplantation. Since cell therapy approaches achieved little success for liver failure treatment, liver TE is considered a more promising alternative. In this study, we produced a liver tissue equivalent (called “liver-derived extracellular matrix scaffold [LEMS]-Patch”) by co-culture of human bone marrow stromal cells, human umbilical vein endothelial cells, and a hepatoma cell line, Huh7, within an artificial three-dimensional liver-extracellular matrix scaffold. The results showed significant increase in the liver-specific gene expression and hepatic functions, in terms of albumin (ALB) and fibrinogen secretion, urea production, and cytochrome inducibility in the LEMS-Patch compared to controls. In addition, transplanted LEMS-Patch was successfully incorporated into the recipient liver of acute liver failure mice and produced human ALB. Consequently, our data demonstrated that the generated LEMS-Patch could be used as a good platform for functional improvement of hepatic cells in vitro and in vivo.
Get full access to this article
View all access options for this article.
References
1.
MorenoR and BerenguerM. (2006). Post-liver transplantation medical complications. Ann Hepatol, 5:77–85.
2.
FukumitsuK, YagiH and Soto-GutierrezA. (2011). Bioengineering in organ transplantation: targeting the liver. Transplant Proc, 43:2137–2138.
3.
ForbesSJ, GuptaS and DhawanA. (2015). Cell therapy for liver disease: from liver transplantation to cell factory. J Hepatol, 62:S157–S169.
4.
HaridassD, NarainN and OttM. (2008). Hepatocyte transplantation: waiting for stem cells. Curr Opin Organ Transplant, 13:627–632.
5.
YiF, LiuGH and Izpisua BelmonteJC. (2012). Human induced pluripotent stem cells derived hepatocytes: rising promise for disease modeling, drug development and cell therapy. Protein Cell, 3:246–250.
6.
LeiteSB, RoosensT, El TaghdouiniA, MannaertsI, SmoutAJ, NajimiM, SokalE, NoorF, ChesneC and van GrunsvenLA. (2016). Novel human hepatic organoid model enables testing of drug-induced liver fibrosis in vitro. Biomaterials, 78:1–10.
7.
MuellerD, TascherG, Müller-VieiraU, KnobelochD, NuesslerAK, ZeilingerK, HeinzleE and NoorF. (2011). In-depth physiological characterization of primary human hepatocytes in a 3D hollow-fiber bioreactor. J Tissue Eng Regen Med, 5:e207-18.
8.
VosoughM, OmidiniaE, KadivarM, ShokrgozarM-A, PournasrB, AghdamiN and BaharvandH. (2013). Generation of functional hepatocyte-like cells from human pluripotent stem cells in a scalable suspension culture. Stem Cells Dev, 22:2693–2705.
9.
FeiziZ, ZahmatkeshE, FarzanehZ, PiryaeiA, GramignoliR, NusslerAK, BaharvandH and VosoughM. (2019). Prenatal liver stromal cells: favorable feeder cells for long-term culture of hepatic progenitor cells. J Cell Biochem, 120:16624–16633.
10.
FarzanehZ, NajaraslM, AbbasalizadehS, VosoughM and BaharvandH. (2018). Developing a cost-effective and scalable production of human hepatic competent endoderm from size-controlled pluripotent stem cell aggregates. Stem Cells Dev, 27:262–274.
11.
HeidariyanZ, GhanianMH, AshjariM, FarzanehZ, NajaraslM, Rezaei LarijaniM, PiryaeiA, VosoughM and BaharvandH. (2018). Efficient and cost-effective generation of hepatocyte-like cells through microparticle-mediated delivery of growth factors in a 3D culture of human pluripotent stem cells. Biomaterials, 159:174–188.
12.
LinT-Y, KiCS and LinC-C. (2014). Manipulating hepatocellular carcinoma cell fate in orthogonally cross-linked hydrogels. Biomaterials, 35:6898–6906.
NagamotoY, TakayamaK, OhashiK, OkamotoR, SakuraiF, TachibanaM, KawabataK and MizuguchiH. (2016). Transplantation of a human iPSC-derived hepatocyte sheet increases survival in mice with acute liver failure. J Hepatol, 64:1068–1075.
15.
SiltanenC, DiakataouM, LowenJ, HaqueA, RahimianA, StybayevaG and RevzinA. (2017). One step fabrication of hydrogel microcapsules with hollow core for assembly and cultivation of hepatocyte spheroids. Acta Biomater, 50:428–436.
16.
OhashiK, YokoyamaT, YamatoM, KugeH, KanehiroH, TsutsumiM, AmanumaT, IwataH, YangJ and OkanoT. (2007). Engineering functional two-and three-dimensional liver systems in vivo using hepatic tissue sheets. Nat Med, 13:880–885.
17.
OhashiK, TatsumiK, TatenoC, KataokaM, UtohR, YoshizatoK and OkanoT. (2012). Liver tissue engineering utilizing hepatocytes propagated in mouse livers in vivo. Cell Transplant, 21:429–436.
18.
KimK, UtohR, OhashiK, KikuchiT and OkanoT. (2017). Fabrication of functional 3D hepatic tissues with polarized hepatocytes by stacking endothelial cell sheets in vitro. J Tissue Eng Regen Med, 11:2071–2080.
19.
BaimakhanovZ, YamanouchiK, SakaiY, KoikeM, SoyamaA, HidakaM, TakatsukiM, FujitaF, KanetakaK, KurokiT and EguchiS. (2016). Efficacy of multilayered hepatocyte sheet transplantation for radiation-induced liver damage and partial hepatectomy in a rat model. Cell Transplant, 25:549–558.
20.
TakebeT, SekineK, EnomuraM, KoikeH, KimuraM, OgaeriT, ZhangR-R, UenoY, ZhengY-W and KoikeN. (2013). Vascularized and functional human liver from an iPSC-derived organ bud transplant. Nature, 499:481–484.
21.
ParkK-M, HusseinKH, HongS-H, AhnC, YangS-R, ParkS-M, KweonO-K, KimB-M and WooH-M. (2016). Decellularized liver extracellular matrix as promising tools for transplantable bioengineered liver promotes hepatic lineage commitments of induced pluripotent stem cells. Tissue Eng Part A, 22:449–460.
22.
ZhouP, LessaN, EstradaDC, SeversonEB, LingalaS, ZernMA, NoltaJA and WuJ. (2011). Decellularized liver matrix as a carrier for the transplantation of human fetal and primary hepatocytes in mice. Liver Transplant, 17:418–427.
23.
YagiH, FukumitsuK, FukudaK, KitagoM, ShinodaM, ObaraH, ItanoO, KawachiS, TanabeM and CoudrietGM. (2013). Human-scale whole-organ bioengineering for liver transplantation: a regenerative medicine approach. Cell Transplant, 22:231–242.
24.
ZhouQ, LiL and LiJ. (2015). Stem cells with decellularized liver scaffolds in liver regeneration and their potential clinical applications. Liver Int, 35:687–694.
25.
WangY, LeeJ-H, ShirahamaH, SeoJ, GlennJS and ChoN-J. (2016). Extracellular matrix functionalization and Huh-7.5 cell coculture promote the hepatic differentiation of human adipose-derived mesenchymal stem cells in a 3D ICC hydrogel scaffold. ACS Biomater Sci Eng, 2:2255–2265.
26.
JiR, ZhangN, YouN, LiQ, LiuW, JiangN, LiuJ, ZhangH, WangD and TaoK. (2012). The differentiation of MSCs into functional hepatocyte-like cells in a liver biomatrix scaffold and their transplantation into liver-fibrotic mice. Biomaterials, 33:8995–9008.
27.
UnderhillGH and KhetaniSR. (2018). Bioengineered liver models for drug testing and cell differentiation studies. Cell Mol Gastroenterol Hepatol, 5:426–439.e1.
28.
RajanN, HabermehlJ, CotéM-F, DoillonCJ and MantovaniD. (2006). Preparation of ready-to-use, storable and reconstituted type I collagen from rat tail tendon for tissue engineering applications. Nat Protoc, 1:2753–2753.
29.
JaffeEA, NachmanRL, BeckerCG and MinickCR. (1973). Culture of human endothelial cells derived from umbilical veins. Identification by morphologic and immunologic criteria. J Clin Invest, 52:2745–2756.
30.
PiryaeiA, ValojerdiMR, ShahsavaniM and BaharvandH. (2011). Differentiation of bone marrow-derived mesenchymal stem cells into hepatocyte-like cells on nanofibers and their transplantation into a carbon tetrachloride-induced liver fibrosis model. Stem Cell Rev Rep, 7:103–118.
31.
ForbesSJ and NewsomePN. (2016). Liver regeneration—mechanisms and models to clinical application. Nat Rev Gastroenterol Hepatol, 13:473–485.
32.
ZareH, JamshidiS, PiryaeiA, DehghanMM, SasaniF, MolaeiS, NasiriF and SadighN. (2015). Induction of acute hepatic failure by carbon tetrachloride in the NMRI mouse model. Qom Univ Med Sci J, 9:74–84.
33.
MaX, QuX, ZhuW, LiY-S, YuanS, ZhangH, LiuJ, WangP, LaiCSE and ZanellaF. (2016). Deterministically patterned biomimetic human iPSC-derived hepatic model via rapid 3D bioprinting. Proc Natl Acad Sci USA, 113:2206–2211.
34.
RebeloSP, CostaR, SilvaMM, MarcelinoP, BritoC and AlvesPM. (2015). Three-dimensional co-culture of human hepatocytes and mesenchymal stem cells: improved functionality in long-term bioreactor cultures. J Tissue Eng Regen Med, 11:2034–2045.
35.
LeeJS, ShinJ, ParkH-M, KimY-G, KimB-G, OhJ-W and ChoS-W. (2013). Liver extracellular matrix providing dual functions of two-dimensional substrate coating and three-dimensional injectable hydrogel platform for liver tissue engineering. Biomacromolecules, 15:206–218.
36.
NakamuraS and IjimaH. (2013). Solubilized matrix derived from decellularized liver as a growth factor-immobilizable scaffold for hepatocyte culture. J Biosci Bioeng, 116:746–753.
37.
LangR, SternMM, SmithL, LiuY, BharadwajS, LiuG, BaptistaPM, BergmanCR, SokerS and YooJJ. (2011). Three-dimensional culture of hepatocytes on porcine liver tissue-derived extracellular matrix. Biomaterials, 32:7042–7052.
38.
LeeH, HanW, KimH, HaD-H, JangJ, KimBS and ChoD-W. (2017). Development of liver decellularized extracellular matrix bioink for three-dimensional cell printing-based liver tissue engineering. Biomacromolecules, 18:1229–1237.
39.
Rajabi-ZeletiS, Jalili-FiroozinezhadS, AzarniaM, KhayyatanF, VahdatS, NikeghbalianS, KhademhosseiniA, BaharvandH and AghdamiN. (2014). The behavior of cardiac progenitor cells on macroporous pericardium-derived scaffolds. Biomaterials, 35:970–982.
40.
TakebeT, KoikeN, SekineK, EnomuraM, ChibaY, UenoY, ZhengY-W and TaniguchiH. (2012). Generation of functional human vascular network. Transplant Proc, 44:1130–1133.
41.
TakebeT, KoikeN, SekineK, FujiwaraR, AmiyaT, ZhengY-W and TaniguchiH. (2014). Engineering of human hepatic tissue with functional vascular networks. Organogenesis, 10:260–267.
42.
SakaiY, YamanouchiK, OhashiK, KoikeM, UtohR, HasegawaH, MuraokaI, SuematsuT, SoyamaA and HidakaM. (2015). Vascularized subcutaneous human liver tissue from engineered hepatocyte/fibroblast sheets in mice. Biomaterials, 65:66–75.
43.
KimMH, KumarSK, ShirahamaH, SeoJ, LeeJH and ChoN-J. (2016). Phenotypic regulation of liver cells in a biofunctionalized three-dimensional hydrogel platform. Integr Biol, 8:156–166.
44.
HannounZ, SteichenC, DianatN, WeberA and Dubart-KupperschmittA. (2016). The potential of induced pluripotent stem cell derived hepatocytes. J Hepatol, 65:182–199.
45.
ShiX, LiuJ, ChenD, ZhuM, YuJ, XieH, ZhouL, LiL and ZhengS. (2019). MSC-triggered metabolomic alterations within liver-resident immune cells isolated from CCl4-induced mouse ALI model detected by CIL LC-MS. Exp Cell Res, 383:111511.
46.
YunJ-W, AhnJH, KwonE, KimS-H, KimH, JangJ-J, KimWH, KimJH, HanS-Y and KimJT. (2016). Human umbilical cord-derived mesenchymal stem cells in acute liver injury: hepatoprotective efficacy, subchronic toxicity, tumorigenicity, and biodistribution. Regul Toxicol Pharmacol, 81:437–447.
47.
DengL, KongX, LiuG, LiC, ChenH, HongZ, LiuJ and XiaJ. (2016). Transplantation of adipose-derived mesenchymal stem cells efficiently rescues thioacetamide-induced acute liver failure in mice. Transplant Proc, 48:2208–2215.
48.
MardpourS, HassaniSN, MardpourS, SayahpourF, VosoughM, AiJ, AghdamiN, HamidiehAA and BaharvandH. (2018). Extracellular vesicles derived from human embryonic stem cell-MSCs ameliorate cirrhosis in thioacetamide-induced chronic liver injury. J Cell Physiol, 233:9330–9344.
49.
HaraguchiY, ShimizuT, SasagawaT, SekineH, SakaguchiK, KikuchiT, SekineW, SekiyaS, YamatoM and UmezuM. (2012). Fabrication of functional three-dimensional tissues by stacking cell sheets in vitro. Nat Protoc, 7:850.
50.
YuanJ, LiW, HuangJ, GuoX, LiX, LuX, HuangX and ZhangH. (2015). Transplantation of human adipose stem cell-derived hepatocyte-like cells with restricted localization to liver using acellular amniotic membrane. Stem Cell Res Ther, 6:217.
51.
ZeilingerK, FreyerN, DammG, SeehoferD and KnöspelF. (2016). Cell sources for in vitro human liver cell culture models. Exp Biol Med, 241:1684–1698.
52.
WuQ, LiuJ, LiuL, ChenY, WangJ, LengL, YuQ, DuanZ and WangY. (2018). Establishment of an ex vivo model of nonalcoholic fatty liver disease using a tissueeEngineered liver. ACS Biomater Sci Eng, 4:3016–3026.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
